Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1981 1
1982 3
1983 1
1984 1
1985 4
1986 3
1987 1
1988 1
1989 1
1990 6
1993 6
1994 4
1995 2
1997 1
1998 2
1999 7
2000 7
2001 5
2002 8
2003 2
2004 4
2005 4
2006 4
2007 7
2008 9
2009 8
2010 12
2011 16
2012 23
2013 25
2014 25
2015 28
2016 28
2017 31
2018 22
2019 22
2020 33
2021 35
2022 36
2023 46
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Results by year

Filters applied: . Clear all
Page 1
Anti-MDA5 dermatomyositis: an update from bench to bedside.
Fuzzi E, Gatto M, Zen M, Franco C, Zanatta E, Ghirardello A, Doria A. Fuzzi E, et al. Among authors: gatto m. Curr Opin Rheumatol. 2022 Nov 1;34(6):365-373. doi: 10.1097/BOR.0000000000000908. Epub 2022 Sep 12. Curr Opin Rheumatol. 2022. PMID: 36094462 Free PMC article. Review.
Post-COVID-19 syndrome: Cardiovascular manifestations.
Tanni SE, Tonon CR, Gatto M, Mota GAF, Okoshi MP. Tanni SE, et al. Among authors: gatto m. Int J Cardiol. 2022 Dec 15;369:80-81. doi: 10.1016/j.ijcard.2022.08.054. Epub 2022 Sep 1. Int J Cardiol. 2022. PMID: 36058345 Free PMC article. No abstract available.
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS).
Zen M, Gatto M, Depascale R, Regola F, Fredi M, Andreoli L, Franceschini F, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo EP, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Cauli A, Scarpato S, Rossi FW, De Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Zanatta E, Larosa M, Saccon F, Doria A, Iaccarino L. Zen M, et al. Among authors: gatto m. J Pers Med. 2023 Apr 20;13(4):691. doi: 10.3390/jpm13040691. J Pers Med. 2023. PMID: 37109077 Free PMC article.
Migraine, Allergy, and Histamine: Is There a Link?
Ferretti A, Gatto M, Velardi M, Di Nardo G, Foiadelli T, Terrin G, Cecili M, Raucci U, Valeriani M, Parisi P. Ferretti A, et al. Among authors: gatto m. J Clin Med. 2023 May 19;12(10):3566. doi: 10.3390/jcm12103566. J Clin Med. 2023. PMID: 37240671 Free PMC article. Review.
When to use belimumab in SLE.
Gatto M, Iaccarino L, Zen M, Doria A. Gatto M, et al. Expert Rev Clin Immunol. 2017 Aug;13(8):737-740. doi: 10.1080/1744666X.2017.1324784. Epub 2017 May 5. Expert Rev Clin Immunol. 2017. PMID: 28463023 No abstract available.
Assessment of disease activity and damage in SLE: Are we there yet?
Cruciani C, Zen M, Gatto M, Morand E, Doria A. Cruciani C, et al. Among authors: gatto m. Best Pract Res Clin Rheumatol. 2023 Dec 2:101896. doi: 10.1016/j.berh.2023.101896. Online ahead of print. Best Pract Res Clin Rheumatol. 2023. PMID: 38044231 Review.
Pulmonary involvement in antisynthetase syndrome.
Gasparotto M, Gatto M, Saccon F, Ghirardello A, Iaccarino L, Doria A. Gasparotto M, et al. Among authors: gatto m. Curr Opin Rheumatol. 2019 Nov;31(6):603-610. doi: 10.1097/BOR.0000000000000663. Curr Opin Rheumatol. 2019. PMID: 31503025 Review.
446 results